# Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease

> **NCT01108978** · PHASE4 · TERMINATED · sponsor: **Nang Kuang Pharmaceutical Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus
- Cardiovascular Disease
- Hypercholesterolemia

## Interventions

- **DRUG:** Placebo
- **DRUG:** Dehypotin

## Key facts

- **NCT ID:** NCT01108978
- **Lead sponsor:** Nang Kuang Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-05
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01108978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01108978, "Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01108978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*